These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 17324475)

  • 21. Antipsychotic drug actions on gene modulation and signaling mechanisms.
    Molteni R; Calabrese F; Racagni G; Fumagalli F; Riva MA
    Pharmacol Ther; 2009 Oct; 124(1):74-85. PubMed ID: 19540875
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Specific involvement of glycogen synthase kinase-3 in the function and activity of sex steroid hormone receptors reveals the complexity of their regulation.
    Grisouard J; Mayer D
    J Steroid Biochem Mol Biol; 2009 Nov; 117(4-5):87-92. PubMed ID: 19703560
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression and function of glycogen synthase kinase-3 in human hair follicles.
    Yamauchi K; Kurosaka A
    Arch Dermatol Res; 2010 May; 302(4):263-70. PubMed ID: 19705135
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association study of -1727 A/T, -50 C/T and (CAA)n repeat GSK-3beta gene polymorphisms with schizophrenia.
    Scassellati C; Bonvicini C; Perez J; Bocchio-Chiavetto L; Tura GB; Rossi G; Racagni G; Gennarelli M
    Neuropsychobiology; 2004; 50(1):16-20. PubMed ID: 15179015
    [TBL] [Abstract][Full Text] [Related]  

  • 25. GSK3B and schizophrenia: a case not closed.
    Sand PG; Domani M; Smesny S
    Psychopharmacology (Berl); 2010 Feb; 208(2):333-4; author reply 335-6. PubMed ID: 19936977
    [No Abstract]   [Full Text] [Related]  

  • 26. GSK3 signalling in neural development.
    Hur EM; Zhou FQ
    Nat Rev Neurosci; 2010 Aug; 11(8):539-51. PubMed ID: 20648061
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dopaminergic intracellular signal integrating proteins: relevance to schizophrenia.
    Souza BR; Souza RP; Rosa DV; Guimarães MM; Correa H; Romano-Silva MA
    Dialogues Clin Neurosci; 2006; 8(1):95-100. PubMed ID: 16640119
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neurodevelopment in schizophrenia: the role of the wnt pathways.
    Panaccione I; Napoletano F; Forte AM; Kotzalidis GD; Del Casale A; Rapinesi C; Brugnoli C; Serata D; Caccia F; Cuomo I; Ambrosi E; Simonetti A; Savoja V; De Chiara L; Danese E; Manfredi G; Janiri D; Motolese M; Nicoletti F; Girardi P; Sani G
    Curr Neuropharmacol; 2013 Sep; 11(5):535-58. PubMed ID: 24403877
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic animal models of schizophrenia related with the hypothesis of abnormal neurodevelopment.
    Lu L; Mamiya T; Koseki T; Mouri A; Nabeshima T
    Biol Pharm Bull; 2011; 34(9):1358-63. PubMed ID: 21881217
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Looking ahead: electroretinographic anomalies, glycogen synthase kinase-3, and biomarkers for neuropsychiatric disorders.
    Chen G; Henter ID; Manji HK
    Biol Psychiatry; 2014 Jul; 76(2):86-8. PubMed ID: 24948381
    [No Abstract]   [Full Text] [Related]  

  • 31. Prospects in GSK-3 Signaling: From Cellular Regulation to Disease Therapy.
    Arciniegas Ruiz S; Rippin I; Eldar-Finkelman H
    Cells; 2022 May; 11(10):. PubMed ID: 35626655
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impairment of phosphatidylinositol 3-kinase signaling in schizophrenia: state or trait?
    Lang UE
    Am J Psychiatry; 2010 Jun; 167(6):719; author reply 719. PubMed ID: 20516168
    [No Abstract]   [Full Text] [Related]  

  • 33. Signal transmission, schizophrenia and the limits to biological psychiatry.
    McLaren N
    Aust N Z J Psychiatry; 2001 Feb; 35(1):130-2. PubMed ID: 11270449
    [No Abstract]   [Full Text] [Related]  

  • 34. Modelling schizophrenia: Opportunities and challenges.
    Tandon R; Bruijnzeel DM
    Asian J Psychiatr; 2017 Feb; 25():A1. PubMed ID: 28262180
    [No Abstract]   [Full Text] [Related]  

  • 35. GSK tops ranking for making drugs available to poor people.
    Coombes R
    BMJ; 2018 Nov; 363():k4919. PubMed ID: 30459205
    [No Abstract]   [Full Text] [Related]  

  • 36. GSK will resume paying doctors to promote its drugs after policy U turn.
    Wise J
    BMJ; 2018 Oct; 363():k4157. PubMed ID: 30282692
    [No Abstract]   [Full Text] [Related]  

  • 37. Converging Perspectives on Schizophrenia.
    Buckley PF
    Psychiatr Clin North Am; 2016 Jun; 39(2):xiii-xiv. PubMed ID: 27216908
    [No Abstract]   [Full Text] [Related]  

  • 38. Save the Children and GSK: Programming for impact.
    Pediatr Pulmonol; 2020 Jun; 55 Suppl 1():S4. PubMed ID: 31985881
    [No Abstract]   [Full Text] [Related]  

  • 39. AKT/GSK3 signaling pathway and schizophrenia.
    Emamian ES
    Front Mol Neurosci; 2012; 5():33. PubMed ID: 22435049
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Single-cell genomics and regulatory networks for 388 human brains.
    Emani PS; Liu JJ; Clarke D; Jensen M; Warrell J; Gupta C; Meng R; Lee CY; Xu S; Dursun C; Lou S; Chen Y; Chu Z; Galeev T; Hwang A; Li Y; Ni P; Zhou X; ; Bakken TE; Bendl J; Bicks L; Chatterjee T; Cheng L; Cheng Y; Dai Y; Duan Z; Flaherty M; Fullard JF; Gancz M; Garrido-Martín D; Gaynor-Gillett S; Grundman J; Hawken N; Henry E; Hoffman GE; Huang A; Jiang Y; Jin T; Jorstad NL; Kawaguchi R; Khullar S; Liu J; Liu J; Liu S; Ma S; Margolis M; Mazariegos S; Moore J; Moran JR; Nguyen E; Phalke N; Pjanic M; Pratt H; Quintero D; Rajagopalan AS; Riesenmy TR; Shedd N; Shi M; Spector M; Terwilliger R; Travaglini KJ; Wamsley B; Wang G; Xia Y; Xiao S; Yang AC; Zheng S; Gandal MJ; Lee D; Lein ES; Roussos P; Sestan N; Weng Z; White KP; Won H; Girgenti MJ; Zhang J; Wang D; Geschwind D; Gerstein M
    bioRxiv; 2024 Mar; ():. PubMed ID: 38562822
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.